Internal Medicine Doctors in Madison, NJ Accepting Medicare

8 Internal Medicine doctors found. Showing 1 - 8

Marc L Benton, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 300 Madison Ave, Suite 201, Madison, NJ 07940 Phone: 973-822-2772    Fax: 973-822-2773

Dr. Vincent Anthony Esposito, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 322 Main St, Madison, NJ 07940 Phone: 973-301-2471    Fax: 973-301-0757

Madiha Latif, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 89 Fairfax Ct, Madison, NJ 07940 Phone: 973-647-2866

Traian Parvulescu, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Shunpike Rd, Madison, NJ 07940 Phone: 973-377-6216    Fax: 973-829-1562

Mary Elisabeth Harris, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Madison Ave Fl 3, Madison, NJ 07940 Phone: 973-822-2772

Dr. Vijay Seelall, M.D. Internal Medicine - Sleep Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Madison Ave, Madison, NJ 07940 Phone: 973-822-2772    Fax: 973-822-2773

Dr. Hany Abdallah, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 27 Elm St Apt 3, Madison, NJ 07940 Phone: 973-443-0052

Jodie Ann Bachman, D.O. Internal Medicine - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 345 Main Street, Madison, NJ 07940 Phone: 973-377-6700    Fax: 973-377-8008

News Archive

Blood pressure near the heart is more predictive of cardiovascular outcomes than blood pressure measured in the arm

Results from a new study show that amlodipine-based (calcium channel blocker) treatment is much more effective at reducing blood pressure near the heart than a conventional atenolol-based (beta blocker) regimen.

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that Japan's Pharmaceuticals and Medical Devices Agency has approved LYNPARZA tablets for use in patients with unresectable or recurrent BRCA-mutated, human epidermal growth factor receptor 2 -negative breast cancer who have received prior chemotherapy.

New computer program can predict underlying genomics of ER+ breast cancer

The number of tubules in tumors may predict which women with estrogen receptor positive (ER+) breast cancer will benefit from hormone therapy alone and which require chemotherapy, researchers at Case Western Reserve University have found.

New research on safest way to position women during labor

New research is challenging what many obstetricians and physician anesthesiologists believe is the best way to position women during labor. According to a study published in the February issue of Anesthesiology, the official medical journal of the American Society of Anesthesiologists, the traditional practice of positioning women on their side, with hips tilted at 15 degrees, during labor does not effectively reduce compression of the inferior vena cava, a large vein located near the abdominal area that returns blood to the heart, as previously thought.

Read more Medical News

› Verified 1 days ago